share_log

Abacus Planning Group Inc. Has $1.16 Million Position in CVS Health Co. (NYSE:CVS)

Abacus Planning Group Inc. Has $1.16 Million Position in CVS Health Co. (NYSE:CVS)

Abacus规划集团持有CVS Health Co.(纽约证券交易所代码:CVS)价值116万美元的股份。
Financial News Live ·  2022/09/24 15:31

Abacus Planning Group Inc. raised its holdings in CVS Health Co. (NYSE:CVS – Get Rating) by 5.1% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 12,566 shares of the pharmacy operator's stock after acquiring an additional 608 shares during the quarter. Abacus Planning Group Inc.'s holdings in CVS Health were worth $1,164,000 as of its most recent SEC filing.

据控股频道报道,Abacus规划集团在第二季度将其在CVS Health Co.(纽约证券交易所代码:CVS-GET)的持股比例提高了5.1%。该机构投资者在本季度额外购买了608股后,持有这家药房运营商的12566股股票。截至最近提交给美国证券交易委员会的文件,算盘规划集团持有的CVS Health股份价值1,164,000美元。

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. Macroview Investment Management LLC increased its stake in CVS Health by 128.3% in the 1st quarter. Macroview Investment Management LLC now owns 242 shares of the pharmacy operator's stock valued at $25,000 after buying an additional 136 shares during the last quarter. Claremont Financial Group Inc. acquired a new stake in CVS Health in the 4th quarter valued at $26,000. Stuart Chaussee & Associates Inc. increased its stake in shares of CVS Health by 123.0% during the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator's stock worth $31,000 after purchasing an additional 171 shares during the last quarter. Rise Advisors LLC acquired a new position in shares of CVS Health during the 4th quarter worth about $41,000. Finally, Carl Stuart Investment Advisor Inc. acquired a new position in shares of CVS Health during the 1st quarter worth about $41,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

其他几家对冲基金和其他机构投资者最近也增持或减持了CVS的股份。宏景投资管理有限责任公司在第一季度增持了128.3%的CVS Health股份。宏景投资管理公司现在拥有242股这家药房运营商的股票,价值25,000美元,在上个季度又购买了136股。克莱蒙特金融集团公司在第四季度收购了CVS Health的新股份,价值2.6万美元。Stuart Chaussee&Associates Inc.在第一季度增持了CVS Health的股份,增幅为123.0%。Stuart Chaussee&Associates Inc.现在持有这家药房运营商310股股票,价值3.1万美元,上个季度又购买了171股。Rise Advisors LLC在第四季度收购了CVS Health的新头寸,价值约41,000美元。最后,卡尔·斯图尔特投资顾问公司在第一季度收购了价值约41,000美元的CVS Health股票。77.64%的股票目前由机构投资者和对冲基金持有。

Get
到达
CVS Health
CVS运行状况
alerts:
警报:

CVS Health Price Performance

CVS健康性价比

Shares of NYSE:CVS traded down $1.48 during midday trading on Friday, hitting $98.35. The stock had a trading volume of 4,647,029 shares, compared to its average volume of 4,427,529. The company's 50-day moving average price is $100.20 and its 200-day moving average price is $99.25. The company has a market capitalization of $129.12 billion, a P/E ratio of 15.99, a price-to-earnings-growth ratio of 1.52 and a beta of 0.73. The company has a quick ratio of 0.65, a current ratio of 0.91 and a debt-to-equity ratio of 0.67. CVS Health Co. has a fifty-two week low of $81.78 and a fifty-two week high of $111.25.

纽约证券交易所:CVS的股价在周五午盘交易中下跌1.48美元,触及98.35美元。该股成交量为4,647,029股,而其平均成交量为4,427,529股。该公司的50日移动均线价格为100.20美元,200日移动均线价格为99.25美元。该公司市值为1,291.2亿美元,市盈率为15.99倍,市盈率为1.52倍,贝塔系数为0.73。该公司的速动比率为0.65,流动比率为0.91,债务权益比率为0.67。CVS Health Co.股价为81.78美元,为52周低点,52周高点为111.25美元。

CVS Health (NYSE:CVS – Get Rating) last released its quarterly earnings data on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.16 by $0.24. The business had revenue of $80.64 billion during the quarter, compared to analysts' expectations of $76.38 billion. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. The firm's quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.42 EPS. As a group, equities research analysts predict that CVS Health Co. will post 8.53 EPS for the current fiscal year.
CVS Health(NYSE:CVS-GET Rating)最近一次发布季度收益数据是在8月3日星期三。这家药房运营商公布本季度每股收益(EPS)为2.40美元,超出分析师普遍预期的2.16美元,超出0.24美元。该业务当季营收为806.4亿美元,高于分析师预期的763.8亿美元。CVS Health的净利润率为2.65%,股本回报率为15.19%。与去年同期相比,该公司的季度收入增长了11.0%。去年同期,该公司每股收益为2.42美元。作为一个整体,股票研究分析师预计CVS Health Co.本财年每股收益将达到8.53欧元。

CVS Health Dividend Announcement

CVS健康股息公告

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 1st. Investors of record on Friday, October 21st will be given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date is Thursday, October 20th. CVS Health's dividend payout ratio is 35.77%.

该公司最近还披露了季度股息,将于11月1日(星期二)支付。10月21日(星期五)登记在册的投资者将获得每股0.55美元的股息。这意味着年化股息为2.20美元,收益率为2.24%。除息日期为10月20日星期四。CVS Health的派息比率为35.77%。

Insider Buying and Selling

内幕买卖

In related news, EVP Alan Lotvin sold 22,541 shares of the company's stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now directly owns 109,183 shares in the company, valued at approximately $11,355,032. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other CVS Health news, EVP Thomas M. Moriarty sold 138,654 shares of the company's stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total value of $13,172,130.00. Following the completion of the transaction, the executive vice president now directly owns 626,273 shares in the company, valued at approximately $59,495,935. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Alan Lotvin sold 22,541 shares of the company's stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now owns 109,183 shares of the company's stock, valued at $11,355,032. The disclosure for this sale can be found here. 0.69% of the stock is owned by corporate insiders.

在相关新闻中,执行副总裁艾伦·洛文在8月4日(星期四)的一笔交易中出售了22,541股公司股票。这些股票的平均价格为104.00美元,总成交金额为2,344,264.00美元。交易完成后,执行副总裁总裁现在直接持有公司109,183股,价值约11,355,032美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站。在CVS Health的其他新闻中,执行副总裁托马斯·M·莫里亚蒂在6月28日星期二的一笔交易中出售了138,654股该公司股票。这些股票的平均价格为95.00美元,总价值为13,172,130.00美元。交易完成后,执行副总裁总裁现在直接持有该公司626,273股,价值约59,495,935美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可在此超链接。此外,执行副总裁艾伦·洛文在8月4日(星期四)的一次交易中出售了22,541股公司股票。这些股票的平均价格为104.00美元,总成交金额为2,344,264.00美元。交易完成后,执行副总裁总裁现在持有该公司109,183股股票,价值11,355,032美元。关于这次销售的披露可以找到这里。0.69%的股份由企业内部人士持有。

Analysts Set New Price Targets

分析师设定新的价格目标

Several research analysts have recently weighed in on CVS shares. UBS Group boosted their price objective on shares of CVS Health from $118.00 to $127.00 and gave the stock a "buy" rating in a research note on Thursday, August 4th. Evercore ISI boosted their price objective on shares of CVS Health from $120.00 to $125.00 and gave the stock an "outperform" rating in a research note on Wednesday, September 7th. Credit Suisse Group lifted their target price on shares of CVS Health from $113.00 to $117.00 and gave the stock an "outperform" rating in a report on Monday, August 8th. Loop Capital started coverage on shares of CVS Health in a report on Thursday, June 16th. They set a "buy" rating and a $120.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of CVS Health from $113.00 to $120.00 in a report on Thursday, August 4th. Four investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $117.59.

几位研究分析师最近纷纷买入CVS股票。瑞银集团将CVS Health的股票目标价从118.00美元上调至127.00美元,并在周四的一份研究报告中给予该股“买入”评级。9月7日,Evercore ISI将CVS Health的股票目标价从120.00美元上调至125.00美元,并在一份研究报告中给予该股“跑赢大盘”的评级。瑞士信贷集团在8月8日周一的一份报告中将CVS Health的目标价从113.00美元上调至117.00美元,并给予该股“跑赢大盘”的评级。Loop Capital在6月16日星期四的一份报告中开始报道CVS Health的股票。他们为该公司设定了“买入”评级和120.00美元的目标价。最后,德意志银行Aktiengesellschaft在8月4日周四的一份报告中将CVS Health的目标价从113.00美元上调至120.00美元。四位投资分析师对该股的评级为持有,19位分析师发布了买入评级,一位分析师对该公司给予了强烈的买入评级。根据MarketBeat的数据,该公司目前的平均评级为“适度买入”,共识目标价为117.59美元。

CVS Health Company Profile

CVS Health公司简介

(Get Rating)

(获取评级)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

CVS Health Corporation在美国提供医疗服务。该公司的医疗福利部门提供传统的、自愿的和以消费者为导向的健康保险产品和相关服务。它为雇主团体、个人、大学生、兼职和小时工、健康计划、医疗保健提供者、政府单位、政府支持的计划、劳工团体和外籍人士提供服务。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on CVS Health (CVS)
  • Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 2 Semiconductor Stocks To Watch For Reversals
  • 免费获取StockNews.com关于CVS Health(CVS)的研究报告
  • 华尔街对Datadog的热情会带来巨大的收益吗?
  • MarketBeat:回顾一周9/19-9/23
  • 为什么特斯拉的股票保持弹性?
  • 小盘股的裁员是楼市的晴雨表吗?
  • 需要关注的2只半导体类股走势逆转

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Get Rating).

想看看还有哪些对冲基金持有简历吗?访问HoldingsChannel.com获取CVS Health Co.(纽约证券交易所代码:CVS-GET Rating)的最新13F文件和内幕交易信息。

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

接受CVS健康日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对CVS Health和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发